This inventor holds 1 USPTO granted patent. Top assignee: Max-Delbruck-Centrum Fur Molekulare Medizin. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Regins Reszka: Innovator in Transfection Efficiency
Introduction
Regins Reszka is a notable inventor based in Schwanebeck, Germany. He has made significant contributions to the field of molecular medicine, particularly in improving transfection efficiency. His innovative approach utilizes K16-peptides, which have the potential to enhance the delivery of genetic material into cells.
Latest Patents
Regins Reszka holds a patent for a method aimed at improving transfection efficiency. This invention specifically relates to the use of K16-peptides, including a novel K16-CYC peptide. His work in this area is crucial for advancing gene therapy and other applications in molecular biology. He has 1 patent to his name.
Career Highlights
Reszka is affiliated with the Max-Delbruck-Centrum für Molekulare Medizin, a leading research institution in Germany. His role at this prestigious center allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Régis Cartier and Michael Böttger. Their collective expertise enhances the research environment and fosters innovation in their projects.
Conclusion
Regins Reszka's work in improving transfection efficiency through K16-peptides represents a significant advancement in molecular medicine. His contributions are paving the way for future innovations in gene therapy and related fields.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile